Slowing the Market: If Not Now, When?
Executive SummaryCaught between consolidation of customers and the aggressive acquisition sprees of large companies, smaller medical device and supply firms are feeling squeezed in the current marketplace. But antitrust complaints against Microsoft indicate that the FTC and the Justice Department are taking seriously small-company complaints that their bigger rivals are conspiring to shut them out of a variety of markets.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.